312.90 USD
▼-17.65-5.34%
盘后 317.00 +1.31%
2026-09-15
市值
$8.74B
市盈率
—
EPS
-12.86
股息率
—
52 周区间
37.25 – 392.70
成交量
205.65K
Beta
2.78
目标价
638.68
52W 低 37.2552W 高 392.70
价格走势
公司简介
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States. The company’s platforms include Cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and Solidus to discover and develop antisense oligonucleotide. It also develops ulixacaltamide, a small molecule inhibitor of T-type calcium channels that in N...